Sujeet Kumar

Consultant Clinical Hematologist| Medanta Lucknow| HematoCare Clinic Varanasi| DM Clinical Hematology (SGPGI)| Ex Associate Prof TMH Varanasi|

[Sujeet Kumar @sujeethemat]

@BlueDartCares Now solve this one
This is also lying with bluedart facility in lucknow

[Sujeet Kumar @sujeethemat]

@BlueDartCares I have not cancelled this order and why would any one cancel prepaid order.
There is clear intention to not deliver this and by Tommorow it will be cancelled by your team.
Waybill no: 90576565866
Kindly make your local team work ro deliver products.

[Sujeet Kumar @sujeethemat]

@BlueDartCares No resolution yet
No contact made from your team. Have already send info through DM

[Sujeet Kumar @sujeethemat]

Great Bluedart
The consignment that was delivered 20 days back as per bluedart was lying with bluedart facility and was delivered today again in 24 days.
See this package left shipper on 20/06 and now has reached me today.
Although the consignment (live plant) is of no use.

[Sujeet Kumar @sujeethemat]

It has become a pattern
Few days back this item worth 1300 was not delivered and was marked delivered at 11:00 pm
I even complained at your portal but got no reply back
AWN mentioned in screenshot

[Sujeet Kumar @sujeethemat]

@Aditya_PGI @HBCHRC_Punjab @docgulia @seemagulia1 @HemeDoc_Pooja Congratulations 👍

[Sujeet Kumar @sujeethemat]

Community Hematology Practice in cities with limited Hematology Services.
Last year in June had started Varanasi Centre with low cost approach and with its success another centre at Gorakhpur is now live.

[HematoCare Clinic @HematoCare]

New Beginning at Gorakhpur HematoCare OPD

Wide variety of malignant and benign hematology patients (DVT, Myeloma, Anemia, Thrombocytopenia, CML) consulted at HematoCare Clinic in gorakhpur on 1st OPD.

Available for consultation on 2nd and 4th Friday/Sunday of every Month.

[Sujeet Kumar @sujeethemat]

@MirghSumeet @Satyayadav__ @nihardesai89 @Shreyas_H @DrUrmiheme @GJaishetwar @NicoGagelmann @ACTREC_TMC @TheEBMT @UdayYanamandra @IndMyAcGp @lingarajnayak @AnantGokar62082 Congratulations sir

[Sujeet Kumar @sujeethemat]

@VijayPa58585596 @TMC_Varanasi Thank You

[Sujeet Kumar @sujeethemat]

@nihardesai7 @ASH_hematology @Hans_BMTProgram @pmcancercentre @UHN @Haemophage @IvanPasic @PanktiMehta24 Congratulations 👍

[Sujeet Kumar @sujeethemat]

@ShekharDivyansh @HematoCare Thank you

[Sujeet Kumar @sujeethemat]

Last working day at Homi Bhabha Cancer Hospital (TMH Varanasi). Three and half years passed by at this institute in a jiffy. Walking back with lots of experience to Lucknow but will keep coming back to Varanasi at @HematoCare

[Sujeet Kumar @sujeethemat]

Also with only malignant cases at cancer hospital - benign Hematology was left behind.
In the meantime BMT also picked up (although I was not a part of BMT team) and centre grew immensely
Eventually got to do academic as well as pharma trials.

[Sujeet Kumar @sujeethemat]

With OPD footfall of 100+ and IPD of 60 patients it was a busy department. Moreover with 2 consultants/SR and 2 JRs it was very difficult to give time to anything other than patient care - so research and academics took back seat.

[Sujeet Kumar @sujeethemat]

Clinical Hematologist working in the department of Medical Oncology 😀

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai7]

Hematologist at #ASCO24 😂😂😂

[Sujeet Kumar @sujeethemat]

@EHA_Hematology
To be considered for a TKI-free interval trial, the patient must have received TKI (imatinib or Nilotinib) for at least 3 years and at least 12 months should
have elapsed after achieving an MMR response.

[Sujeet Kumar @sujeethemat]

The TKI-free interval
that could be given to patients was in range of 27-39 weeks. All of these six patients
achieved MMR after restating TKI within 3-9 months.
https://t.co/Bc6zuTRM4t

[Sujeet Kumar @sujeethemat]

Just Published: Indian experience with use of nilotinib (non generic)
n = 126 patients
MMR and MR4 at 12 months was seen in 40.7% and 17.6% patients respectively.
https://t.co/IP3mHD0uGo

[Sujeet Kumar @sujeethemat]

@nihardesai7 @EHA_Hematology @lingarajnayak @bagalbp @MirghSumeet @drsanjeev1980 Thank you 🙏

[Sujeet Kumar @sujeethemat]

5 abstracts selected for the @EHA_Hematology annual meeting in #Madrid 🇪🇸

Particularly happy to see the abstract on concept of TKI free interval for planned pregnancy getting selected.